Clinical Trial Update: Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial investigating gemcitabine and pemetrexed disodium in advanced mycosis fungoides or Sézary syndrome (a form of cutaneous T-cell lymphoma) has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2018-10-09